. . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer"@en . . "427"^^ . . . . . . . . . . . . . . . . . "A Phase III, Randomized, Open-Label, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane\u00AE) as Maintenance Treatment After Induction With Nab-Paclitaxel Plus Carboplatin in Subjects With Squamous Cell Non-Small Cell Lung Cancer (NSCLC)"@en . "18"^^ . . "ensayu cl\u00EDnicu"@ast . "Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer"@en . . . "NCT02027428" . . "2014-02-11T00:00:00Z"^^ . . . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . . . . . . . "klinisch onderzoek"@nl . . . . . . . . . . . . . "Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer"@en . . . . . "2017-09-15T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . .